AHEAD 3-45

Lecanemab for the treatment of early Alzheimer’s disease: the story so far 2:02
Lecanemab for the treatment of early Alzheimer’s disease: the story so far
Chad Swanson • 13 Aug 2021
Major ongoing clinical trials in AD: aducanumab, donanemab & lecanemab 1:32
Major ongoing clinical trials in AD: aducanumab, donanemab & lecanemab
Stephen Salloway • 13 Aug 2021
Phase III AHEAD 3-45 trial of lecanemab for preclinical Alzheimer’s disease 1:57
Phase III AHEAD 3-45 trial of lecanemab for preclinical Alzheimer’s disease
Chad Swanson • 13 Aug 2021
The content of VJDementia is intended for healthcare professionals